In thisstudy, we demonstrated that both EGFR mRNA and its promoter activity were inhibitedby HDAC inhibitors in colon cancer cells, indicating that the denovo synthesis of EGFR was transcriptionally inhibited. The gene discussed is HDAC9; the disease is malignant colon neoplasm.